Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Aarti Pharmalabs Ltd Performance

Today's Low
487.85
arrowIcon
Today's High
518.70
52 Wk Low
320.30
arrowIcon
52 Wk High
566.95


Open

493.65

Traded Value (Cr)

5.09 Cr

Prev. Close

492.55

VWAP

498.93

Volume

93,188

Face Value

5

Aarti Pharmalabs Ltd Fundamentals

Market Cap
₹ 4,487 Cr
P/E Ratio (TTM)
23.07
P/B Ratio
2.71
Debt to Equity
0.13
ROE
11.43 %
EPS (TTM)
21.46
Dividend Yield
0.40%
Book Value
182.90

Click here to know more about Fundamentals

Aarti Pharmalabs Ltd Financials

Aarti Pharmalabs Ltd Financials

Aarti Pharmalabs Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 46.46 % 46.46 % 46.30 % 45.98 %
Retail 29.71 % 29.74 % 29.13 % 30.23 %
Others 12.79 % 13.59 % 13.45 % 13.64 %
FII 8.33 % 8.16 % 8.45 % 7.43 %
Mutual Funds 2.72 % 2.05 % 2.67 % 2.72 %

Promoters

46.46%

Retail

29.71%

Others

12.79%

FII

8.33%

Mutual Funds

2.72%

Promoters

46.46%

Retail

29.74%

Others

13.59%

FII

8.16%

Mutual Funds

2.05%

Promoters

46.30%

Retail

29.13%

Others

13.45%

FII

8.45%

Mutual Funds

2.67%

Promoters

45.98%

Retail

30.23%

Others

13.64%

FII

7.43%

Mutual Funds

2.72%

Resistance and Support

₹504.17

PIVOT

resistance-arrow
Resistance
First Resistance₹514.733
Second Resistance₹524.717
Third Resistance₹535.283
support-arrow
Support
First Resistance₹494.183
Second Resistance₹483.617
Third Resistance₹473.633
RSI44.480
MACD21.034
ADX55.413
CCI4.473

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day93,18841,77644.83
Week105,99947,55945.18
1 Month204,910124,06254.89
6 Months121,83445,26437.15

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date. Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. 9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.

Managing Director

Hetal Gogri Gala

Founded

2019

NSE Symbol

AARTIPHARM

Aarti Pharmalabs Ltd Management

NameDesignation
Rashesh C GogriChairman
Hetal Gogri GalaVice Chairperson & MD
Narendra Jagannath SalviManaging Director
Rajendra V GogriNon-Exec & Non-Independent Dir
Parimal H DesaiNon Executive Director
Bhavesh R VoraIndependent Director
Vinay Gopal NayakIndependent Director
Vilas G GaikarIndependent Director
Jeenal SavlaIndependent Director
Rupal VoraIndependent Director

Aarti Pharmalabs Ltd News

Aarti Pharmalabs to discuss results
On 13 May 2024
Board of Aarti Pharmalabs recommends interim dividend
Of Rs 2 per share
Aarti Pharmalabs fixes record date for interim dividend
Record date is 19 February 2024
Board of Aarti Pharmalabs recommends interim dividend
Of Rs 2 per share
Aarti Pharmalabs consolidated net profit rises 10.65% in the December 2023 quarter
Sales decline 4.86% to Rs 448.69 crore
Aarti Pharmalabs announces board meeting date
On 7 February 2024
Aarti Pharmalabs consolidated net profit rises 1.39% in the September 2023 quarter
Sales decline 17.20% to Rs 439.80 crore
Aarti Pharmalabs to convene board meeting
On 7 November 2023
Aarti Pharmalabs to hold AGM
On 14 September 2023
Aarti Pharmalabs consolidated net profit declines 9.16% in the June 2023 quarter
Sales rise 0.22% to Rs 458.36 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,616 Cr
₹ 1,503.00
(0.56 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,387.70
(2.13 %)
33.36
DIVISLAB₹ 1,00,611 Cr
₹ 3,778.15
(-0.31 %)
73.75
DRREDDY₹ 98,044 Cr
₹ 5,885.80
(0.14 %)
22.59
ZYDUSLIFE₹ 97,423 Cr
₹ 981.25
(1.35 %)
36.23

Aarti Pharmalabs Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Aarti Pharmalabs Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Aarti Pharmalabs Ltd's share price is ₹504.50 as of May 10, 2024

Aarti Pharmalabs Ltd's P/E ratio is 23.07 times as of May 10, 2024.

Aarti Pharmalabs Ltd's most recent financial reports indicate a price-to-book ratio of 2.71, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Aarti Pharmalabs Ltd's market is 4,487 Cr as on May 10, 2024.

The current financial records of Aarti Pharmalabs Ltd show a 11.43% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Aarti Pharmalabs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Aarti Pharmalabs Ltd's 52-week high and low as of May 10, 2024 are ₹518.7 and ₹487.85 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Aarti Pharmalabs Ltd stands at 46.46%. During the same period, Institutional Investors have shown a slight increase in their holdings, rising from 8.16% to 8.33%.